Expert group meeting on paediatric heart failure

German is available via eTranslation, the European Commission's machine translation service.

Translate to German | Important information about machine translation

Date

Montag, 29 November 2010, Ganztägig

Ort

European Medicines Agency, Amsterdam, the Netherlands

The meeting is identifying priorities for and the optimal design of studies on drug development in paediatric heart failure (HF) for the purpose of the evaluation of paediatric investigation plans. The main topics include new drug classes in the pipeline and priority list for HF drugs in children, types of paediatric HF to be studied, trial design issues and the establishment of a paediatric cardiology network.

Documents

Share this page